Tags : SelectSite C304-HIS Deflectable Catheter System

Medtronic’s SelectSite C304-HIS Deflectable Catheter System Receives FDA’s Clearance for

Tuba Khan May 30, 2019

Shots: Medtronic reports FDA’s clearance & launch of SelectSite C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing The catheter system features a deflectable out-of-plane curve to reach […]readmore

Tags : SelectSite C304-HIS Deflectable Catheter System

Medtronic’s SelectSite C304-HIS Deflectable Catheter System Receives FDA’s Clearance for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : SelectSite C304-HIS Deflectable Catheter System

﻿Medtronic’s SelectSite C304-HIS Deflectable Catheter System Receives FDA’s Clearance for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

Medtronic’s SelectSite C304-HIS Deflectable Catheter System Receives FDA’s Clearance for